EU backs approval of Moderna’s COVID-19 vaccine in 12-17 year-olds
Pharma Times
JULY 27, 2021
Study in adolescents met it primary endpoint, successfully bridging immune responses to those observed in an efficacy study in adults
Sat.Jul 24, 2021 - Fri.Jul 30, 2021
168 
Rapid COVID immune status test launched in UK, Ireland
pharmaphorum
JULY 26, 2021
You’ve had your two COVID-19 jabs, but are you actually protected against infection? That’s a question that a fingerprick test launched today in the UK and Ireland could help to answer. The test – originally developed by US manufacturer Chembio Diagnostics – has been introduced into the UK and Irish markets by Guilford-based Luas Diagnostics and tests for the presence of SARS-CoV-2-targeting antibodies in the blood.
Join 11,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Crisis Communications and FDA
Eye on FDA
JULY 29, 2021
In the face of a crisis situation, it is a given that the clarity and thoroughness of the communications response is key to resolving the issue and mitigating any reputational damage. Perhaps no other decision by the Food and Drug Administration has garnered as much controversy, as the recent one to authorize the accelerated approval a new treatment for Alzheimer’s.
Pharma industry, CROs adapting to COVID-19 impacts: survey
Outsourcing Pharma
JULY 27, 2021
A recent check-in with several biopharma and CRO companies, conducted by Life Science Strategy Group, indicates adjustment to pandemic-related challenges.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Study shows AZ’s COVID-19 jab did not increase the rate of rare blood clots after second dose
Pharma Times
JULY 28, 2021
Rate of rare blood clots with low platelets after the second dose is comparable to background rates observed in unvaccinated populations
Google’s DeepMind puts human proteome online for free
pharmaphorum
JULY 26, 2021
The most complete database of protein structures ever assembled, developed with the help of Google’s artificial intelligence unit DeepMind, has been made freely available to researchers around the world. DeepMind partnered with the European Molecular Biology Laboratory (EMBL) to come up with the AlphaFold database, which predicts the three-dimensional structures of the human proteome – nearly all (98.5%) of the 20,000 or so proteins expressed by the human genome.
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
More Trending
BMS, BridgeBio partner to study drug combo for lung cancer
Outsourcing Pharma
JULY 27, 2021
The two pharma firms will partner to study the efficacy of Opdivo, paired with a SHP2 inhibitor, to treat non-small cell lung cancer with KRAS mutations.
Four-drug combo therapy shows benefit for newly-diagnosed myeloma patients
Pharma Times
JULY 26, 2021
Combo therapy includes carflizomib administered alongside lenalidomide, dexamethasone and cyclophosphamide
Why digital doctors are crucial for the future of primary care
pharmaphorum
JULY 28, 2021
Our primary care system is weathering a storm on several fronts. Demand is skyrocketing, with GPs delivering millions more appointments than in previous years and workload far outstripping pre-Covid-19 levels. Dr Dan Bunstone explores how innovation can help GPs overcome the current capacity squeeze in primary care and tackle patient backlog. Despite the misconception that general practice has been ‘closed’ during the pandemic, practice staff are supporting a growing number of patients whose l
Most prolific drug patent challengers
Drug Patent Watch
JULY 26, 2021
This chart shows the generic pharmaceutical companies that had the most successful drug patent challenges from 2016 to 2021. Companies that successfully challenge patents on branded drugs are granted six…. The post Most prolific drug patent challengers appeared first on DrugPatentWatch - Make Better Decisions.
Why Every Small Business Needs an HCM Solution: A Comprehensive Guide
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
New eLearning program aimed at enabling faster clinical adoption and improving patient access to ATMPs
Outsourcing Pharma
JULY 26, 2021
A new UK eLearning program is targeted at healthcare and academic professionals to support their learning on advanced therapy medicinal products (ATMPs).
NICE publishes new draft guideline covering rehabilitation after traumatic injury
Pharma Times
JULY 27, 2021
A traumatic injury includes any injury that requires admission to hospital at the time of injury, according to NICE
Tackling the ‘disease of systemic racism’ in clinical trials
pharmaphorum
JULY 26, 2021
A lack of racial diversity in clinical trials is a long-standing, well-documented problem that contributes to the stark health inequalities that have been brought into sharp focus by COVID-19. Tackling it, however, has not been easy, thanks in no small part to the reasons being as complex as they are multi-faceted. But, according to the Pharmaceutical Research and Manufacturers of America (PhRMA), the country’s biopharmaceutical companies are “committed to learning and leading” in a bid to “addr
Which pharmaceutical companies have the most SPCs in Slovakia?
Drug Patent Watch
JULY 24, 2021
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Slovakia. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…. The post Which pharmaceutical companies have the most SPCs in Slovakia? appeared first on DrugPatentWatch - Make Better Decisions.
Best Practices to Streamline Compensation Management: A Foundation for Growth
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Personalized medicine requires complex supply chains: Marken
Outsourcing Pharma
JULY 26, 2021
A clinical trial logistics expert discusses specialized concerns involved in transporting cell and gene products and other personalized medicine items.
UK genomics market valued at over £5bn, according to new report
Pharma Times
JULY 30, 2021
‘Genomics Nation’ report launched in a bid to showcase the thriving UK genomics sector
Aptar makes digital health play, agreeing deal to buy Voluntis
pharmaphorum
JULY 27, 2021
Drug delivery specialist Aptar Group has agreed a deal to take a near two-thirds share in Voluntis, a French developer of digital therapeutics (DTx), with a view to taking full control of the company later this year. Illinois-headquartered Apar – which makes inhalers, syringe components, eye drop bottles and other delivery systems for pharmaceuticals, cosmetics and other sectors – is paying €8.70 per share in the initial deal, which will give it a 64.6% stake in the company.
Which pharmaceutical drugs have the most drug patents in Cyprus?
Drug Patent Watch
JULY 30, 2021
This chart shows the drugs with the most patents in Cyprus. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…. The post Which pharmaceutical drugs have the most drug patents in Cyprus? appeared first on DrugPatentWatch - Make Better Decisions.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Personalized medicine supply chain highly complex: Marken
Outsourcing Pharma
JULY 26, 2021
A clinical trial logistics expert discusses specialized concerns involved in transporting cell and gene products and other personalized medicine items.
NICE publishes ‘rapid’ guideline on rare blood clots associated with COVID-19 jab
Pharma Times
JULY 30, 2021
Although condition is extremely rare, it requires ‘swift diagnosis and urgent treatment’ says NICE
How tech-driven hubs in specialty pharmacy can improve the patient experience
pharmaphorum
JULY 29, 2021
The use of specialty drugs in the U.S. has skyrocketed in recent years driven primarily by an increase in chronic condition diagnosis and the number of new medications on the market. Krishnanjan Alaparthi explores how tech-driven hub services can help manage the complexities of specialty pharma. It’s estimated specialty medications account for 75% of the approximately 7,000 prescription drugs currently in development, and by 2022, more than 60% of the 600 drugs expected to gain FDA approval will
Vaccine Makers Are Asked to Expand Safety Studies on Children
NY Times
JULY 26, 2021
The F.D.A. wants Pfizer and Moderna to increase the number of 5- to 11-year-olds who participate in trials of their coronavirus vaccines to ensure there is enough data about rare side effects.
Enhance Healthcare Efficiency With Top Payroll & HCM Services
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Pharmaceutical companies with the most orphan drugs
Drug Patent Watch
JULY 27, 2021
Orphan drug exclusivity is granted to drugs addressing rare ‘orphan diseases’ — those affecting fewer than 200,000 Americans. The protection granted to orphan drugs is quite strong. The FDA is…. The post Pharmaceutical companies with the most orphan drugs appeared first on DrugPatentWatch - Make Better Decisions.
Sanofi, Regeneron’s Dupixent wins positive results in chronic spontaneous urticaria
Pharma Times
JULY 29, 2021
CSU is the fifth disease for which Dupixent has positive Phase III data, according to Sanofi and Regeneron
FDA clears Medtronic AI algorithms for cardiac monitoring
pharmaphorum
JULY 29, 2021
Two artificial intelligence (AI) algorithms designed to diagnose people with heart rhythm abnormalities have been approved by the FDA for use with Medtronic’s LINQ II cardiac monitor. The AccuRhythm algorithms can be used to improve the accuracy of detecting atrial fibrillation (AF) – an irregular or rapid rhythm in the upper chambers of the heart – and asystole, a long pause between heartbeats.
U.S. Authorities Seek Documents From Troubled Covid Vaccine Manufacturer
NY Times
JULY 30, 2021
Emergent BioSolutions, which ruined 75 million vaccine doses at its Baltimore plant, disclosed records requests from Congress and federal and state law enforcement agencies.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
FDA grants Breakthrough Device designation to digital therapeutic
Outsourcing Pharma
JULY 29, 2021
The BiovitalsHF, from Biofourmis, is intended to augment decision-making in clinical environments, and to supplement traditional pharmaceutical therapies.
Macomics secures £4.24m to accelerate macrophage-based therapeutics portfolio
Pharma Times
JULY 29, 2021
The company was co-founded in 2019 by Jeffrey Pollard and Luca Cassetta of the University of Edinburgh
Martin Shkreli’s $7.4m forfeit is paid, thanks to that Wu-Tang Clan album
pharmaphorum
JULY 28, 2021
The US government has sold off the one-of-a-kind Wu-Tang Clan album famously bought by ‘pharma bro’ Martin Shkreli, with the proceeds enough to wipe out his $7.4 million fine for defrauding investors. Shkreli , the pharma entrepreneur who became notorious in 2015 for hiking the price of a lifesaving drug, bought the Once Upon a Time in Shaolin album for $2 million in 2015, but surrendered it to the US authorities in 2018 after his conviction.
Some Are Chasing Extra Vaccine Shots, While Scientists Debate
NY Times
JULY 29, 2021
Boosters may not be necessary yet, many experts say, and the pursuit of additional shots raises ethical questions.
Expanding Healthcare Technology Across the Care Team to Improve Medication Access
Drug Channels
JULY 30, 2021
Today’s guest post comes from David Holladay, President of Access and Adherence at CoverMyMeds. David discusses how common medication access, adherence, and affordability barriers can lead patients to abandon important therapies. He suggests that technology can connect providers with actionable information at the point of care, thereby giving patients access to data that can lead them to make better decisions.
Let's personalize your content